What are the techniques for pleurodesis using Betadin (povidone-iodine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pleurodesis with Povidone-Iodine (Betadine): Technique and Protocol

Povidone-iodine pleurodesis is a safe, effective, and low-cost alternative to talc for managing recurrent malignant pleural effusions and pneumothorax, with success rates of 88-98% comparable to talc's 90-93%, though it lacks formal inclusion in major Western guidelines. 1

Patient Selection Criteria

Before attempting povidone-iodine pleurodesis, confirm the following:

  • Complete lung re-expansion is mandatory - verify with chest radiograph after fluid drainage, as trapped lung or bronchial obstruction will cause treatment failure 1, 2
  • Symptomatic dyspnea that improves with therapeutic thoracentesis 1
  • Life expectancy sufficient to benefit from the procedure (generally >1 month) 1
  • Absence of active pleural infection 1

Critical contraindications include trapped lung and mainstem bronchial obstruction, as these prevent necessary pleural surface apposition. 1

Step-by-Step Procedure Protocol

1. Chest Tube Insertion

  • Insert a small-bore intercostal catheter (10-14 F) under ultrasound guidance 3, 1
  • Small-bore tubes are associated with less discomfort than large-bore tubes while maintaining equivalent success rates 3

2. Pleural Fluid Drainage

  • Drain pleural fluid in a controlled fashion, limiting removal to 1-1.5 L at a time to prevent re-expansion pulmonary edema 1, 2
  • Continue drainage until minimal or no pleural fluid remains 1
  • Confirm complete lung re-expansion with chest radiograph before proceeding 3, 1

3. Premedication

  • Administer intravenous narcotic and anxiolytic-amnestic agents before the procedure 1
  • Instill lignocaine solution (3 mg/kg; maximum 250 mg) into the pleural space for local analgesia 3, 1

4. Povidone-Iodine Instillation

The standard protocol involves:

  • Mix 20 mL of 10% povidone-iodine with 80 mL of normal saline (total volume 100 mL) 4
  • Add 2 mg/kg of lidocaine to the mixture for additional analgesia 4
  • Instill the solution through the chest tube when complete lung expansion is confirmed 4

5. Post-Instillation Management

  • Clamp the chest tube for 1-2 hours after instillation 1, 4
  • Patient rotation during the clamping period is not definitively established for povidone-iodine, though rotation is recommended for talc slurry 1
  • After unclamping, maintain the patient on -20 cm H₂O suction 1

6. Chest Tube Removal

  • Remove the chest tube when 24-hour drainage is less than 150-200 mL 1, 4
  • If drainage remains excessive (≥250 mL/24 h) after 48-72 hours, consider repeat instillation 1

Expected Outcomes and Success Rates

  • Complete response (no recurrence) occurs in 88-98% of patients 1, 5, 4
  • Success rates are comparable to talc (90-93%) and superior to bleomycin (61%) and doxycycline (76-85%) 1
  • Mean follow-up data shows sustained efficacy at 5.6-10.2 months 5, 4

Complications and Management

Common Adverse Events

  • Chest pain occurs in 16-27% of patients during or immediately after instillation 4, 6, 7
    • Manage with immediate analgesics; pain is typically mild and self-limited 5, 6
  • Fever occurs in approximately 11% of patients 6
    • Treat with antipyretics; typically resolves within 24-48 hours 1

Serious Complications

  • No procedure-related mortality has been reported in multiple studies 5, 4, 6
  • Pleural empyema is rare (<2%) and responds to drainage and antibiotics 4
  • No risk of acute respiratory failure or ARDS, unlike talc which carries a small (<1%) risk with small-particle preparations 1
  • Thyroid and renal function changes are not clinically significant 7

Critical Pitfalls to Avoid

  • Never attempt pleurodesis without confirming complete lung re-expansion - check post-drainage chest radiograph for mediastinal shift and full lung expansion 1, 2
  • Avoid corticosteroids at the time of pleurodesis, as they reduce pleural inflammatory reaction and increase failure rates 3, 2
  • Do not remove more than 1.5 L during initial drainage to prevent re-expansion pulmonary edema 1, 2
  • Do not perform intercostal tube drainage without pleurodesis, as this has nearly 100% recurrence rate at 1 month 2

Comparison with Standard Agents

Povidone-iodine offers several advantages:

  • Lower cost than bleomycin with superior success rates (90.6% vs 61%) 1
  • Easier administration than talc poudrage - can be performed at bedside without thoracoscopy 4, 8
  • Excellent safety profile - no respiratory failure risk unlike talc 1
  • Readily available in most healthcare settings, particularly valuable in resource-constrained environments 5, 6

However, talc remains the guideline-recommended first-line agent when maximum success rate is critical and thoracoscopy is planned for diagnostic purposes 1. Povidone-iodine is not mentioned in major British Thoracic Society or American Thoracic Society guidelines despite comparable efficacy 1.

Management of Failed Pleurodesis

If povidone-iodine pleurodesis fails:

  • Repeat pleurodesis with the same agent or consider switching to talc 1
  • Thoracoscopy with talc poudrage if initial slurry method was used 1
  • Indwelling pleural catheter for patients with nonexpandable lung or multiple failed attempts 1, 2
  • Repeated thoracentesis for patients with very limited life expectancy 1, 2

References

Guideline

Pleurodesis Procedure Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Pleural Effusions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.